Pulmonary hypertension in sickle cell disease: Cardiac catheterization results and survival

Blood

Volumn 101, Issue 4, 2003, Pages 1257-1261

  Castro, Oswaldo ^a   Hoque, Mohammed ^a   Brown, Bernice D ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COR PULMONALE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HUMAN; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SICKLE CELL ANEMIA; SUDDEN DEATH; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

EID: 0037441758     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0948     Document Type: Article

References (28)

1. Sutton LL, Castro O, Cross DJ, et al. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74:626-628.
2. Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am. 1996;10:1289-1303.
3. Al-Sukhun S, Aboubakr SE, Girgis RE, Swerdlow PS. Pulmonary hypertension is present in 10-30% of adult patients with sickle cell disease [abstract]. Blood 2000;96(suppl 1):9a.
4. Collins FS, Orringer EP. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med. 1982;73:814-821.
5. Case records of the Massachusetts General Hospital (case 52-1983). N Engl J Med. 1983;309:1627-1636.
6. Hammond TG, Mosesson MW. Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease. Arch Intern Med. 1989;149:447-448.
7. Durant JR, Cortes FM. Occlusive pulmonary vascular disease associated with hemoglobin SC disease. Am Heart J. 1966;71:100-106.
8. Yung GL, Channick RN, Fedullo PF, et al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med. 1998;157:1690-1693.
9. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results form a national prospective registry. Ann Intern Med. 1991;115:343-349,
10. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine. 1988;67:66-76.
11. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216-223.
12. Fyke FA III, Mair DD, Smith HC. Cardiac catheterization and angiography. A: Techniques and structures. In: Brandenburg RO, Fuster V, Giuliani ER, McGoon DC, eds. Cardiology: Fundamentals and Practice. Chicago, IL: Year Book Medical Publishers; 1987:415-450.
13. Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clin Proc. 2000;75:625-630.
14. Dawkins FW, Kim KS, Squires RS, et al. Cancer incidence and mortality rate in sickle cell disease patients at Howard University Hospital: 1986-1995. Am J Hematol. 1997;55:188-192.
15. Lewis JF, Maron BJ, Castro O, Moosa YA. Left ventricular diastolic filling abnormalities identified by Doppler echocardiography in asymptomatic patients with sickle cell anemia. J Am Coll Cardiol. 1991;17:1473-1478.
16. Norris SL, Johnson C, Haywood LJ. Left ventricular filling pressure in sickle cell anemia. J Assoc Acad Minor Phys. 1992;3:20-23.
17. Braden DS, Covitz W, Milner PF. Cardiovascular function during rest and exercise in patients with sickle-cell anemia and coexisting alpha thalassemia-2. Am J Hematol. 1996;52:96-102.
18. Clyne CA, Alpert JS, Benotti JR. Interdependence of the left and right ventricles in health and disease. Am Heart J. 1989;117:1366-1373.
19. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
20. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296-302.
21. McLaughlin V, Genthner DE, Panella MM, Hess DM, Rich S. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1999;130:740-743
22. Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002;165:800-804.
23. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-329.
24. Channick, RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001;359:1119-1123.
25. Claster S, Hammer M, Hagar W, Ataga K, Orringer E, Vichinsky E. Treatment of pulmonary hypertension in sickle cell disease with transfusion [abstract]. Blood. 1999;94(Suppl 1):420a.
26. Perez-Penate G, Julia-Serda G, Pulido-Duque JM, Gorriz-Gomez E, Cabrera-Navarro P. One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest. 2001;119:970-973.
27. Nagaya N, Uematsu M, Oya H, et al. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med. 2001;163:887-891.
28. Morris CR, Hagar W, van Warmerdam J, et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease [abstract]. Blood 2000;96(suppl 1):485a.